BSE filing, NSE: CIFL. Summary written from the filing by ALFA Finder's alert engine.
Capital India Finance Ltd: key numbers
- Share price
- ₹19.63
- Market cap
- ₹767.6 Cr
- Revenue (annual)
- ₹528.0 Cr
- Net profit (annual)
- ₹38.89 Cr
- P/E (TTM)
- 19.9×Sector 19.7×
- Promoter holding
- 72.59%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capital India Finance Ltd
All →Capital India Finance Debt & Borrowing
Capital India Finance Limited filed the statement of outstanding debt securities ISIN-wise for the half-year ended September 30, 2026, as required by SEBI regulations.
Capital India Finance Management Change
Capital India Finance Ltd appointed Mr. Hitesh Kumar as Company Secretary and Mr. Simarjeet Singh as Chief Compliance Officer, both effective October 5, 2026.
Capital India Finance Debt & Borrowing: ₹100 Cr
Capital India Finance Limited allotted secured non-convertible debentures worth ₹100 Crore to raise funds for its operations.
- Value
- ₹100.0 Cr
- Execution
- 27 Months
Capital India Finance Credit Rating
Acuite Ratings & Research assigned a 'ACUITE A-' rating to Capital India Finance's proposed Non-Convertible Debentures of INR 100 Crore.
Capital India Finance Debt & Borrowing: ₹100 Cr
Capital India Finance approved the issuance of secured NCDs worth ₹100 Crore via private placement. The issuance includes a base size of ₹50 Crore.
- Value
- ₹100.0 Cr
Capital India Finance Management Change
Mr. Sulabh Kaushal has resigned as Chief Compliance Officer, Company Secretary, and Key Managerial Personnel of Capital India Finance Ltd, effective September 07, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.